• Home
  • Two is better than one: combining IGF1R and MEK blockade as a promising novel treatment strategy against KRAS-mutant lung cancer.

Two is better than one: combining IGF1R and MEK blockade as a promising novel treatment strategy against KRAS-mutant lung cancer.

Author List
Chen R, Sweet-Cordero EA
Publication
Cancer discovery
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1170623
Publication Year
2013
PubMed ID
23658296
Publication Title
Chen R, Sweet-Cordero EA. Two is better than one: combining IGF1R and MEK blockade as a promising novel treatment strategy against KRAS-mutant lung cancer. Cancer Discov. 2013 May; 3(5):491-3.